Back to ICD-10 codes
L91ICD-10-CM

Chapter 12 · L00–L99 · Skin & Subcutaneous Tissue

Hypertrophic disorders of skin

L91 is the ICD10 code used for documenting Hypertrophic disorders of skin in dermatology, wound care, and post-surgical assessments.

What L91 covers · when clinicians use it

ICD-10 code L91 identifies Hypertrophic disorders of skin in the U.S. ICD-10-CM clinical and billing record set. It sits within the Skin & Subcutaneous Tissue chapter (L00–L99), the section that groups related diagnoses so providers, payers, and public-health agencies report them consistently. Clinicians and medical coders apply L91 when an encounter's findings match the Hypertrophic disorders of skin description, attaching it to the patient record so downstream insurance claims, payer audits, quality reporting, and epidemiological surveillance all reference the same standardized diagnosis. The ICD-10-CM is maintained by the Centers for Medicare & Medicaid Services and the CDC's National Center for Health Statistics, with an updated official code set released each U.S. fiscal year — always verify L91 against the current CMS/CDC release and your payer's documentation guidance before final use. This page summarizes documentation context for L91 and is a coding reference, not clinical, diagnostic, or billing advice.

L91 refers to Hypertrophic disorders of skin, which includes a diverse set of skin and subcutaneous tissue disorders such as pigmentary changes, ulcerative lesions, connective tissue diseases, procedural complications, and keratinization issues. These often require multidisciplinary care and long-term monitoring.

Symptoms

  • Skin discoloration – Found in vitiligo (L80), pigmentation disorders (L81), or lupus (L93)
  • Thickening or hardening of skin – Seen in keratoderma (L86), calluses (L84), or hypertrophic skin (L91)
  • Painful skin ulcers – Found in L88, L89, or chronic leg ulcers (L97)
  • Scarring or skin atrophy – Occurs in L90 or procedural issues (L76)
  • Visible plaques or nodules – Associated with granulomatous (L92) or autoimmune causes (L95)

Diagnosis

Diagnosis of Hypertrophic disorders of skin includes patient history, skin examination, biopsy, dermoscopy, wound staging (e.g., pressure ulcers), and immunological tests when autoimmune conditions are suspected.

ICD10 Code Usage

ICD10 code L91 is used by dermatologists, wound care nurses, surgeons, rheumatologists, and internal medicine doctors. It helps document complex skin conditions for treatment, insurance claims, and chronic disease monitoring.

Related Codes

FAQs

Q1: What is ICD10 code L91?
A: It refers to Hypertrophic disorders of skin, encompassing disorders such as skin thickening, ulceration, pigmentation loss, inflammation, or surgical complications.

Q2: What’s the difference between L89 and L97 ulcers?
A: L89 refers to pressure-related ulcers (bedsores), while L97 documents non-pressure chronic ulcers often due to vascular issues or diabetes.

Q3: Is vitiligo (L80) considered autoimmune?
A: Yes, it is thought to have an autoimmune component where melanocytes are destroyed by the immune system.

Q4: What does L76 include?
A: L76 includes infections, scarring, or necrosis occurring as complications of skin procedures like grafts, surgery, or cosmetic treatments.

Q5: Who treats these conditions?
A: Dermatologists, wound care teams, rheumatologists, plastic surgeons, and sometimes infectious disease specialists.

Conclusion

ICD10 code L91 enables precise diagnosis and ongoing documentation of Hypertrophic disorders of skin, supporting specialized care, procedural tracking, and effective dermatologic or systemic disease management.

Source: ICD-10-CM (CMS / CDC NCHS official code set)

Last reviewed:

This page is a documentation reference for the ICD-10-CM code set and is not clinical, diagnostic, or billing advice. Always verify codes against the official ICD-10-CM source and your payer's guidelines.

Stop searching codes. Start delivering care.

Augustun captures the visit, drafts the note, and proposes ICD-10 codes with rationale — trusted by 10,000+ clinicians.